Prostate Cancer Patients With Biochemical Recurrence

Completed

Conditions studied: Patients With Prostate Cancer

In brief

Evaluation of detection rate of 18F-Fluciclovine compared to current standard of care imaging techniques within 30 days of the standard of care imaging study and a 6 month phone follow-up

Key facts

Study ID

NCT03527199

Run by

Medhat Osman

People needed

65

Starts

2018-12-18

Expected to finish

2023-04-10

Last updated by the study team

2023-04-11

Who can join

Age: 18 and older, up to 89. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 and ≤89
• History of Prostate Cancer which required surgical resection or radiation
• Documented Biochemical recurrence defined as a positive PSA any time after the initial diagnosis of prostate cancer which at that time required surgical resection or radiation and then had a negative result to a post treatment PSA.
• Patient undergoing standard of care work up pelvic CT or MRI, 99mTc-MDP bone scan, and F18 NaF PET/CT.

You may not qualify if…

• BCR with negative 99mTc-MDP bone scan but 18F-NaF PET/CT was not able to be done.

Where it is running

• John Cochran VA Medical Center St. Louis — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.